Loading clinical trials...
Loading clinical trials...
Exploring the Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients: an Open, Prospective, and Self-controlled Study
Conditions
Interventions
Dapagliflozin
Locations
1
China
The People's Hospital of Gaozhou
Maoming, Guangdong, China
Start Date
March 1, 2024
Primary Completion Date
August 31, 2024
Completion Date
August 31, 2024
Last Updated
April 15, 2024
Lead Sponsor
The People's Hospital of Gaozhou
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions